|
1
|
Han Q, Lin Q, Jin S and You L: Coronavirus
2019-nCoV: A brief perspective from the front line. J Infect.
80:373–377. 2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Deng SQ and Peng HJ: Characteristics of
and public health responses to the coronavirus disease 2019
outbreak in China. J Clin Med. 9(575)2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Coronaviridae Study Group of the
International Committee on Taxonomy of Viruses. The species severe
acute respiratory syndrome-related coronavirus: Classifying
2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 5:536–544.
2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Zhu N, Zhang D, Wang W, Li X, Yang B, Song
J, Zhao X, Huang B, Shi W, Lu R, et al: A Novel coronavirus from
patients with pneumonia in China, 2019. N Engl J Med. 382:727–733.
2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Wu F, Zhao S, Yu B, Chen YM, Wang W, Song
ZG, Hu Y, Tao ZW, Tian JH, Pei YY, et al: A new coronavirus
associated with human respiratory disease in China. Nature.
579:265–269. 2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Zhou P, Yang XL, Wang XG, Hu B, Zhang L,
Zhang W, Si HR, Zhu Y, Li B, Huang CL, et al: A pneumonia outbreak
associated with a new coronavirus of probable bat origin. Nature.
579:270–273. 2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Chan JF, Kok KH, Zhu Z, Chu H, To KK, Yuan
S and Yuen KY: Genomic characterization of the 2019 novel
human-pathogenic coronavirus isolated from a patient with atypical
pneumonia after visiting Wuhan. Emerg Microbes Infect. 9:221–236.
2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Lu R, Zhao X, Li J, Niu P, Yang B, Wu H,
Wang W, Song H, Huang B, Zhu N, et al: Genomic characterisation and
epidemiology of 2019 novel coronavirus: Implications for virus
origins and receptor binding. Lancet. 395:565–574. 2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Masters PS and Sturman LS: Background
paper. Functions of the coronavirus nucleocapsid protein. Adv Exp
Med Biol. 276:235–238. 1990.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Mu J, Xu J, Zhang L, Shu T, Wu D, Huang M,
Ren Y, Li X, Geng Q, Xu Y, et al: SARS-CoV-2-encoded nucleocapsid
protein acts as a viral suppressor of RNA interference in cells.
Sci China Life Sci. 63:1413–1416. 2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Chen K, Xiao F, Hu D, Ge W, Tian M, Wang
W, Pan P, Wu K and Wu J: SARS-CoV-2 nucleocapsid protein interacts
with RIG-I and represses RIG-mediated IFN-β production. Viruses.
13(47)2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Mu J, Fang Y, Yang Q, Shu T, Wang A, Huang
M, Jin L, Deng F, Qiu Y and Zhou X: SARS-CoV-2 N protein
antagonizes type I interferon signaling by suppressing
phosphorylation and nuclear translocation of STAT1 and STAT2. Cell
Discov. 6(65)2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Netea MG, Schlitzer A, Placek K, Joosten
LAB and Schultze JL: Innate and adaptive immune memory: An
evolutionary continuum in the host's response to pathogens. Cell
Host Microbe. 25:13–26. 2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Ding SW, Han Q, Wang J and Li WX:
Antiviral RNA interference in mammals. Curr Opin Immunol.
54:109–114. 2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Sadler AJ and Williams BRG:
Interferon-inducible antiviral effectors. Nat Rev Immunol.
8:559–568. 2008.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Mick DU, Fox TD and Rehling P: Inventory
control: Cytochrome c oxidase assembly regulates mitochondrial
translation. Nat Rev Mol Cell Biol. 12:14–20. 2011.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Dudkina NV, Kouril R, Peters K, Braun HP
and Boekema EJ: Structure and function of mitochondrial
supercomplexes. Biochim Biophys Acta. 1797:664–670. 2010.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Acín-Pérez R, Bayona-Bafaluy MP,
Fernández-Silva P, Moreno-Loshuertos R, Pérez-Martos A, Bruno C,
Moraes CT and Enríquez JA: Respiratory complex III is required to
maintain complex I in mammalian mitochondria. Mol Cell. 13:805–815.
2004.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Lamort AS, Giopanou I, Psallidas I and
Stathopoulos GT: Osteopontin as a link between inflammation and
cancer: The thorax in the spotlight. Cells. 8(815)2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Saheb Sharif-Askari F, Saheb Sharif-Askari
N, Goel S, Hafezi S, Assiri R, Al-Muhsen S, Hamid Q and Halwani R:
SARS-CoV-2 attenuates corticosteroid sensitivity by suppressing
DUSP1 expression and activating p38 MAPK pathway. Eur J Pharmacol.
908(174374)2021.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Goel S, Saheb Sharif-Askari F, Saheb
Sharif Askari N, Madkhana B, Alwaa AM, Mahboub B, Zakeri AM, Ratemi
E, Hamoudi R, Hamid Q and Halwani R: SARS-CoV-2 switches ‘on’ MAPK
and NFκB signaling via the reduction of nuclear DUSP1 and DUSP5
expression. Front Pharmacol. 12(631879)2021.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Tripathy AS, Vishwakarma S, Trimbake D,
Gurav YK, Potdar VA, Mokashi ND, Patsute SD, Kaushal H, Choudhary
ML, Tilekar BN, et al: Pro-inflammatory CXCL-10, TNF-α, IL-1β, and
IL-6: Biomarkers of SARS-CoV-2 infection. Arch Virol.
166:3301–3310. 2021.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Polidoro RB, Hagan RS, de Santis Santiago
R and Schmidt NW: Overview: Systemic inflammatory response derived
from lung injury caused by SARS-CoV-2 infection explains severe
outcomes in COVID-19. Front Immunol. 11(1626)2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Atri C, Guerfali FZ and Laouini D: Role of
human macrophage polarization in inflammation during infectious
diseases. Int J Mol Sci. 19(1801)2018.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu
Y, Zhang L, Fan G, Xu J, Gu X, et al: Clinical features of patients
infected with 2019 novel coronavirus in Wuhan, China. Lancet.
395:497–506. 2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Chen G, Wu D, Guo W, Cao Y, Huang D, Wang
H, Wang T, Zhang X, Chen H, Yu H, et al: Clinical and immunological
features of severe and moderate coronavirus disease 2019. J Clin
Invest. 130:2620–2629. 2020.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Abdin SM, Elgendy SM, Alyammahi SK,
Alhamad DW and Omar HA: Tackling the cytokine storm in COVID-19,
challenges and hopes. Life Sci. 257(118054)2020.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Han H, Ma Q, Li C, Liu R, Zhao L, Wang W,
Zhang P, Liu X, Gao G, Liu F, et al: Profiling serum cytokines in
COVID-19 patients reveals IL-6 and IL-10 are disease severity
predictors. Emerg Microbes Infect. 9:1123–1130. 2020.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Katakura T, Miyazaki M, Kobayashi M,
Herndon DN and Suzuki F: CCL17 and IL-10 as effectors that enable
alternatively activated macrophages to inhibit the generation of
classically activated macrophages. J Immunol. 172:1407–1413.
2004.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Vuolteenaho K, Koskinen A, Kukkonen M,
Nieminen R, Päivärinta U, Moilanen T and Moilanen E: Leptin
enhances synthesis of proinflammatory mediators in human
osteoarthritic cartilage-mediator role of NO in leptin-induced
PGE2, IL-6, and IL-8 production. Mediators Inflamm.
2009(345838)2009.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Marks F, Klingmüller U and Müller-Decker
K: Cellular signal processing: An introduction to the molecular
mechanisms of signal transduction. 2nd edition. Garland Science.
2017.
|
|
32
|
Ceraolo C and Giorgi FM: Genomic variance
of the 2019-nCoV coronavirus. J Med Virol. 92:522–528.
2020.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Cojocaru C, Cojocaru E, Turcanu AM and
Zaharia DC: Clinical challenges of SARS-CoV-2 variants (Review).
Exp Ther Med. 23(416)2022.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Flores-Vega VR, Monroy-Molina JV,
Jiménez-Hernández LE, Torres AG, Santos-Preciado JI and
Rosales-Reyes R: SARS-CoV-2: Evolution and emergence of new viral
variants. Viruses. 14(653)2022.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Scovino AM, Dahab EC, Vieira GF,
Freire-de-Lima L, Freire-de-Lima CG and Morrot A: SARS-CoV-2's
variants of concern: A brief characterization. Front Immunol.
13(834098)2022.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Yun JS, Song H, Kim NH, Cha SY, Hwang KH,
Lee JE, Jeong CH, Song SH, Kim S, Cho ES, et al: Glycogen synthase
kinase-3 interaction domain enhances phosphorylation of SARS-CoV-2
nucleocapsid protein. Mol Cells. 45:911–922. 2022.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Wu H, Xing N, Meng K, Fu B, Xue W, Dong P,
Tang W, Xiao Y, Liu G, Luo H, et al: Nucleocapsid mutations
R203K/G204R increase the infectivity, fitness, and virulence of
SARS-CoV-2. Cell Host Microbe. 29:1788–1801.e6. 2021.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Dinesh DC, Chalupska D, Silhan J, Koutna
E, Nencka R, Veverka V and Boura E: Structural basis of RNA
recognition by the SARS-CoV-2 nucleocapsid phosphoprotein. PLoS
Pathog. 16(e1009100)2020.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Bai Z, Cao Y, Liu W and Li J: The
SARS-CoV-2 nucleocapsid protein and its role in viral structure,
biological functions, and a potential target for drug or vaccine
mitigation. Viruses. 13(1115)2021.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Carlson CR, Asfaha JB, Ghent CM, Howard
CJ, Hartooni N, Safari M, Frankel AD and Morgan DO:
Phosphoregulation of phase separation by the SARS-CoV-2 N protein
suggests a biophysical basis for its dual functions. Mol Cell.
80:1092–1103.e4. 2020.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Liang F: Quantitative mutation analysis of
genes and proteins of major SARS-CoV-2 variants of concern and
interest. Viruses. 15(1193)2023.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Hossain A, Akter S, Rashid AA, Khair S and
Alam ASMRU: Unique mutations in SARS-CoV-2 Omicron subvariants'
non-spike proteins: Potential impacts on viral pathogenesis and
host immune evasion. Microb Pathog. 170(105699)2022.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Rodrigues-da-Silva RN, Conte FP, da Silva
G, Carneiro-Alencar AL, Gomes PR, Kuriyama SN, Neto AAF and
Lima-Junior JC: Identification of B-cell linear epitopes in the
nucleocapsid (N) protein B-cell linear epitopes conserved among the
main SARS-CoV-2 variants. Viruses. 15(923)2023.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Lee E, Sandgren K, Duette G, Stylianou VV,
Khanna R, Eden JS, Blyth E, Gottlieb D, Cunningham AL and Palmer S:
Identification of SARS-CoV-2 nucleocapsid and spike T-cell epitopes
for assessing T-cell immunity. J Virol. 95:e02002–20.
2021.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Oliveira SC, de Magalhães MTQ and Homan
EJ: Immunoinformatic analysis of SARS-CoV-2 nucleocapsid protein
and identification of COVID-19 vaccine targets. Front Immunol.
11(587615)2020.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Verhagen J, van der Meijden ED, Lang V,
Kremer AE, Völkl S, Mackensen A, Aigner M and Kremer AN: Human
CD4+ T cells specific for dominant epitopes of
SARS-CoV-2 Spike and Nucleocapsid proteins with therapeutic
potential. Clin Exp Immunol. 205:363–378. 2021.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Pacheco-Olvera DL, Saint Remy-Hernández S,
García-Valeriano MG, Rivera-Hernández T and López-Macías C:
Bioinformatic analysis of B- and T-cell epitopes from SARS-CoV-2
structural proteins and their potential cross-reactivity with
emerging variants and other human coronaviruses. Arch Med Res.
53:694–710. 2022.PubMed/NCBI View Article : Google Scholar
|
